External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patients

J Acquir Immune Defic Syndr. 2006 May;42(1):127-8. doi: 10.1097/01.qai.0000219776.27798.e7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Atazanavir Sulfate
  • Drug Resistance, Viral / genetics
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Protease / genetics
  • HIV Protease Inhibitors / pharmacology
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1 / drug effects*
  • HIV-1 / enzymology
  • HIV-1 / genetics*
  • Humans
  • Mutation
  • Oligopeptides / pharmacology*
  • Oligopeptides / therapeutic use
  • Pyridines / pharmacology*
  • Pyridines / therapeutic use
  • Ritonavir / pharmacology*
  • Species Specificity

Substances

  • HIV Protease Inhibitors
  • Oligopeptides
  • Pyridines
  • Atazanavir Sulfate
  • HIV Protease
  • Ritonavir